查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565678

胸膜痛治疗市场，按诊断、治疗、管理模式、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Pleurodynia Treatment Market, By Diagnosis, By Treatment, By Mode of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，胸痛治疗市场规模为1.309亿美元，2024年至2032年复合年增长率为5.90%。

胸膜痛治疗市场-市场动态

由于病毒感染增加，胸膜痛病例的发生率上升。

胸膜痛通常由柯萨奇病毒等病毒感染引起，由于病毒感染的增加，病例数增加。这一趋势反映在胸膜痛治疗市场上，随着越来越多的病例被诊断和管理，该市场也在不断增长。病毒感染，尤其是在寒冷季节流行的病毒感染，会导致胸膜痛的发生率增加。

世界卫生组织 (WHO) 透过其全球健康估算提供相关资料。根据他们的 2021 年报告，病毒感染，包括引起胸膜痛的病毒感染，在过去十年中显着增加。具体而言，2010 年至2020 年间，导致胸膜痛等呼吸道症状的病毒感染发生率上升了约20%。市场的扩张。

胸膜痛治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 5.90% 左右的复合年增长率成长

根据诊断类型细分，预计血液检测将在 2023 年显示最大的市场份额

根据治疗细分，止痛药和止痛药是 2023 年的主要类型

依给药方式细分，2023年口服药物为主导类型

按地区划分，北美是 2023 年的主要收入来源

胸膜痛治疗市场-細項分析：

全球胸膜痛治疗市场根据诊断、治疗、给药模式、最终用户和地区进行细分。

根据诊断型血液检查、培养检查和X光检查，市场分为三类。在胸膜痛治疗市场中，血液检查是最重要的诊断部分。这种重要性是由于它们能够识别通常引起胸膜痛的潜在病毒或细菌感染。血液检查可以揭示发炎和感染的标记物，这对于诊断胸膜痛并将其与其他类似病症区分开来至关重要。虽然也使用培养测试和 X 射线，但血液检查可以提供更直接和可操作的见解，使其成为诊断过程的核心并指导适当的治疗策略。

根据治疗止痛药或止痛药免疫球蛋白将市场分为两类在胸膜痛治疗市场中，止痛药或止痛药是最重要的治疗部分。这种突出源于它们在控制与胸膜痛相关的严重疼痛方面的主要作用，这对于缓解患者症状和提高生活品质至关重要。镇痛药可以有效缓解急性不适，让患者恢復得更舒适。虽然免疫球蛋白可用于针对潜在的病毒原因，但止痛药的使用更为广泛，可以直接解决对患者影响最大的症状，使其成为主要的治疗选择。

胸膜疼痛治疗市场 - 地理洞察

在北美，由于人们认识的提高和医学的进步，胸膜痛治疗市场正在经历显着增长。病毒感染是胸膜痛的常见原因，其流行正在推动对有效治疗的需求。美国和加拿大引领市场，高度重视研究和发展以增强治疗选择。成熟的医疗保健基础设施的存在和医疗保健支出的增加有助于市场扩张。此外，不断增长的老年人口更容易受到这种情况的影响，进一步推动了市场的成长。儘管如此，治疗费用高昂以及需要对治疗效果进行更全面的临床研究等挑战仍然存在。

胸膜痛治疗市场-竞争格局：

胸膜痛治疗市场竞争格局的特点是存在几个积极参与疗法开发和商业化的关键参与者。诺华製药公司、辉瑞公司和葛兰素史克公司等主要製药公司利用其广泛的研究能力和市场影响力，在这一领域表现突出。勃林格殷格翰有限公司和阿斯特捷利康公司也是重要贡献者，专注于创新治疗解决方案并扩大其诊断产品组合。默克公司和强生公司是为市场带来强大治疗选择的关键参与者。此外，礼来公司、赛诺菲公司和艾伯维公司等公司因其对新疗法开发和策略市场定位的贡献而闻名。这些公司透过持续的研究、临床试验和引入新疗法来推动竞争，旨在解决胸膜痛患者未满足的需求。

最新进展：

2023 年1 月，在verywellhealth（一个线上获奖资源，提供一系列健康相关主题的可靠和事实资讯）的一篇文章中，患者可以使用布洛芬（Advil）等非类固醇抗发炎药来控制与胸膜痛相关的疼痛。此外，他们建议在受影响的区域使用热敷袋也可能有助于缓解疼痛。

目录

第 1 章：胸膜痛治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 胸膜痛治疗市场片段（依诊断）
    • 胸膜痛治疗市场片段（依治疗）
    • 依管理模式分類的胸膜痛治疗市场片段
    • 胸膜痛治疗市场片段（依技术）
    • 按国家/地区分類的胸膜痛治疗市场片段
    • 按地区分類的胸膜痛治疗市场片段
  • 竞争洞察

第 3 章：胸膜痛治疗主要市场趋势

  • 胸膜痛治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 胸膜痛治疗市场限制
    • 市场限制影响分析
  • 胸膜痛治疗市场机会
  • 胸膜痛治疗市场未来趋势

第 4 章：胸膜痛治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：胸膜痛治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：胸膜痛治疗市场格局

  • 2023 年胸膜痛治疗市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：胸膜痛治疗市场 - 透过诊断

  • 概述
    • 透过诊断进行细分市场份额分析
    • 验血
    • 文化测试
    • X射线

第 8 章：胸膜痛治疗市场 - 按治疗分类

  • 概述
    • 按处理方式分類的细分市场占有率分析
    • 镇痛药或止痛药
    • 免疫球蛋白

第 9 章：胸膜痛治疗市场 - 按给药方式

  • 概述
    • 按管理模式分類的细分市场占有率分析
    • 口服
    • 注射或输液

第 10 章： 胸膜痛治疗市场 - 由最终用户

  • 概述
    • 按处理方式分類的细分市场占有率分析
    • 医院
    • 药局
    • 其他的

第 11 章：胸膜痛治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美胸膜痛治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模及预测（按诊断）
    • 北美市场规模与预测（以不同处理方式）
    • 北美市场规模与预测（按管理模式）
    • 北美市场规模和预测（按技术）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲胸膜痛治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（透过诊断）
    • 欧洲市场规模与预测（按处理方式）
    • 欧洲市场规模与预测（按管理模式）
    • 欧洲市场规模与预测（按技术）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区胸膜痛治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模及预测（依诊断）
    • 亚太地区市场规模与预测（以不同处理方式）
    • 亚太地区市场规模与预测（依管理模式）
    • 亚太地区市场规模与预测（按技术）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲胸膜痛治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按诊断）
    • 拉丁美洲市场规模与预测（以不同处理方式）
    • 拉丁美洲市场规模与预测（按管理模式）
    • 拉丁美洲市场规模与预测（按技术）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲胸膜痛治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按诊断）
    • 中东及非洲市场规模及预测（依不同处理方式）
    • 中东和非洲市场规模及预测（依管理模式）
    • 中东和非洲市场规模及预测（按技术）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析-胸膜痛治疗产业

  • 竞争仪表板
  • 公司简介
    • Novartis Pharmaceuticals Corporation
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Boehringer Ingelheim GmbH
    • AstraZeneca plc
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Eli Lilly and Company
    • Sanofi
    • AbbVie Inc.
    • Roche Holding AG
    • Takeda Pharmaceutical Company Limited
    • Mylan NV
    • Amgen Inc.
    • Bristol-Myers Squibb Company

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3888

REPORT HIGHLIGHT

The Pleurodynia Treatment Market size was valued at USD 130.90 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

Pleurodynia is a condition characterized by sharp, stabbing pain in the chest due to inflammation of the pleura, the membrane surrounding the lungs. It often results from viral infections, such as those caused by the Coxsackievirus. Treatment typically focuses on relieving pain and addressing the underlying cause. Over-the-counter pain relievers like ibuprofen or acetaminophen are commonly used, alongside rest and sometimes corticosteroids for more severe cases. The market for pleurodynia treatment includes pharmaceutical companies developing pain management medications and diagnostic tools, as well as healthcare providers offering tailored treatment plans.

Pleurodynia Treatment Market- Market Dynamics

Rising incidence of pleurodynia cases due to increased viral infections.

Pleurodynia, often caused by viral infections such as coxsackievirus, has seen a rise in cases due to an increase in viral infections. This trend is reflected in the Pleurodynia Treatment market, which is growing as more cases are diagnosed and managed. Viral infections, particularly those prevalent in colder seasons, contribute to the increased incidence of pleurodynia.

The World Health Organization (WHO) provides relevant data through its Global Health Estimates. According to their 2021 report, viral infections, including those causing pleurodynia, have seen a significant increase over the past decade. Specifically, the incidence of viral infections causing respiratory symptoms, including pleurodynia, rose by approximately 20% between 2010 and 2020. This rise in cases emphasizes the growing need for effective treatments and interventions, driving the pleurodynia treatment market's expansion.

Pleurodynia Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Diagnosis type segmentation, Blood tests was predicted to show maximum market share in the year 2023

Based on Treatment segmentation, Analgesics, and pain killers was the leading type in 2023

Based on Mode of Administration segmentation, Oral Medicines was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pleurodynia Treatment Market- Segmentation Analysis:

The Global Pleurodynia Treatment Market is segmented on the basis of Diagnosis, Treatment, Mode of Administration, End-User, and Region.

The market is divided into three categories based on Diagnosis type Blood test, culture test, and X-ray. In the pleurodynia treatment market, blood tests are the most significant diagnostic segment. This prominence is due to their ability to identify underlying viral or bacterial infections that commonly cause pleurodynia. Blood tests can reveal markers of inflammation and infection, which are crucial for diagnosing and differentiating pleurodynia from other similar conditions. While culture tests and X-rays are also used, blood tests provide more immediate and actionable insights, making them central to the diagnostic process and guiding appropriate treatment strategies.

The market is divided into two categories based on Treatment Analgesics or Painkillers Immunoglobulin In the pleurodynia treatment market, analgesics or painkillers are the most significant treatment segment. This prominence stems from their primary role in managing the severe pain associated with pleurodynia, which is essential for patient relief and quality of life. Analgesics address the acute discomfort effectively, allowing patients to recover more comfortably. While immunoglobulins may be used to target underlying viral causes, analgesics are more widely utilized and directly address the symptom that most affects patients, making them the dominant treatment option.

Pleurodynia Treatment Market- Geographical Insights

In North America, the pleurodynia treatment market is experiencing notable growth due to increasing awareness and advancements in medicine. The prevalence of viral infections, which are a common cause of pleurodynia, is driving demand for effective treatments. The United States and Canada lead the market, with a high focus on research and development to enhance treatment options. The presence of established healthcare infrastructure and the rise in healthcare expenditure contribute to market expansion. Moreover, the growing geriatric population, which is more susceptible to such conditions, further fuels market growth. Despite this, challenges such as high treatment costs and the need for more comprehensive clinical studies on treatment efficacy remain.

Pleurodynia Treatment Market- Competitive Landscape:

The competitive landscape of the pleurodynia treatment market is characterized by the presence of several key players who are actively involved in the development and commercialization of therapies. Major pharmaceutical companies like Novartis Pharmaceuticals Corporation, Pfizer Inc., and GlaxoSmithKline plc are prominent in this space, leveraging their extensive research capabilities and market reach. Boehringer Ingelheim GmbH and AstraZeneca plc are also significant contributors, focusing on innovative treatment solutions and expanding their Diagnosis portfolios. Merck & Co., Inc. and Johnson & Johnson are key players that bring robust therapeutic options to the market. Additionally, companies such as Eli Lilly and Company, Sanofi, and AbbVie Inc. are notable for their contributions to the development of new treatments and strategic market positioning. These companies drive competition through ongoing research, clinical trials, and the introduction of novel therapies, aiming to address the unmet needs of patients with pleurodynia.

Recent Developments:

In January 2023, in an article on verywellhealth, an online award-winning resource that offers reliable and factual information on a range of health-related topics, patients can manage their pleurodynia-related pain with nonsteroidal anti-inflammatory drugs such as ibuprofen (Advil), even though there isn't a specific treatment for the condition. Additionally, they proposed that applying warm packs to the afflicted area might also aid in pain relief.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLEURODYNIA TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Novartis Pharmaceuticals Corporation
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Boehringer Ingelheim GmbH
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Eli Lilly and Company
  • Sanofi
  • AbbVie Inc.
  • Roche Holding AG
  • Takeda Pharmaceutical Company Limited
  • Mylan N.V.
  • Amgen Inc.
  • Bristol-Myers Squibb Company

GLOBAL PLEURODYNIA TREATMENT MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood test
  • Culture test
  • X-ray

GLOBAL PLEURODYNIA TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Analgesics or Painkillers
  • Immunoglobulin

GLOBAL PLEURODYNIA TREATMENT MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injections or infusion

GLOBAL PLEURODYNIA TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Pharmacy
  • Others

GLOBAL PLEURODYNIA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pleurodynia Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pleurodynia Treatment Market Snippet by Diagnosis
    • 2.1.2. Pleurodynia Treatment Market Snippet by Treatment
    • 2.1.3. Pleurodynia Treatment Market Snippet by Mode of Administration
    • 2.1.4. Pleurodynia Treatment Market Snippet by Technology
    • 2.1.5. Pleurodynia Treatment Market Snippet by Country
    • 2.1.6. Pleurodynia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Pleurodynia Treatment Key Market Trends

  • 3.1. Pleurodynia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pleurodynia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pleurodynia Treatment Market Opportunities
  • 3.4. Pleurodynia Treatment Market Future Trends

4. Pleurodynia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pleurodynia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pleurodynia Treatment Market Landscape

  • 6.1. Pleurodynia Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pleurodynia Treatment Market - By Diagnosis

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2. Blood test
    • 7.1.3. Culture test
    • 7.1.4. X-ray

8. Pleurodynia Treatment Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 8.1.2. Analgesics or Painkillers
    • 8.1.3. Immunoglobulin

9. Pleurodynia Treatment Market - By Mode of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
    • 9.1.2. Oral
    • 9.1.3. Injections or infusion

10. Pleurodynia Treatment Market - By End Users

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Pharmacy
    • 10.1.4. Others

11. Pleurodynia Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Pleurodynia Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Pleurodynia Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Pleurodynia Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Pleurodynia Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Pleurodynia Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pleurodynia Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Novartis Pharmaceuticals Corporation
    • 12.2.2. Pfizer Inc.
    • 12.2.3. GlaxoSmithKline plc
    • 12.2.4. Boehringer Ingelheim GmbH
    • 12.2.5. AstraZeneca plc
    • 12.2.6. Merck & Co., Inc.
    • 12.2.7. Johnson & Johnson
    • 12.2.8. Eli Lilly and Company
    • 12.2.9. Sanofi
    • 12.2.10. AbbVie Inc.
    • 12.2.11. Roche Holding AG
    • 12.2.12. Takeda Pharmaceutical Company Limited
    • 12.2.13. Mylan N.V.
    • 12.2.14. Amgen Inc.
    • 12.2.15. Bristol-Myers Squibb Company

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us